









Street View: Biogen's path to investor confidence hinges on stronger results

ReutersAug 1, 2025 1:07 PM

Biogen BIIB.O raised its annual profit forecast and beat estimates for quarterly results on Thursday, as strong demand for its rare disease drugs largely countered declining sales of its older multiple sclerosis treatments

GROWTH CATALYSTS NEEDED

Piper Sandler ("neutral", PT: $115) says even though Biogen's product pipeline is advancing, it's still far from driving sustainable revenue growth

Oppenheimer ("outperform", PT: $205) sees rare disease as a future growth driver with stable Spinraza demand and positive trends for Skyclarys launch

Jefferies ("hold", PT: $130) says "the big picture reality is to get this stock significantly higher - they need positive Phase III pipeline catalyst readouts and a big new shiny thing to get investors 're-engaged' to drive investor confidence"

Morningstar (fair value: $220) expects Biogen's financial outlook to remain unaffected by tariff constraints in 2025 due to its high inventory levels

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Tradingkey

Recommended Articles

SpaceX IPO Seeks to Raise Over 50 Billion: Will This Largest-Ever Capital Flow Be Injected Into Bitcoin?

SpaceX may increase its Bitcoin holdings following an IPO to support the development of the Grok model and spatial AI data centers.

Should You Buy Upcoming SpaceX Now or Tesla After a 20% Pullback?

TradingKey - Media reports indicate that SpaceX, founded by Tesla (TSLA.US) CEO Elon Musk, plans to file its IPO prospectus with regulators later this week or next week. The company aims to raise more than $75 billion in the IPO, exceeding the previously reported $50 billion. Its latest valuation is

USDC Architect Circle Plummets 20% as U.S. Lawmakers Target Stablecoin Interest

Regulatory headwinds triggered a plunge of more than 20% in Circle’s share price, yet ARK Invest bucked the trend by purchasing over $20 million.

Pop Mart Revenue Tops 30 Billion Net Profit Surges 284%, Why Did Stock Price Plummet 15%?

TradingKey - On March 25, following the release of Pop Mart's (09992.HK) 2025 annual results, its Hong Kong-listed shares plummeted by as much as 15% intraday. Although the full-year performance was robust and generally aligned with market expectations, investor dissatisfaction was directly reflected in the stock price.

SpaceX IPO Approaches: Behind the $75 Billion Fundraising Rumors, What Is the Capital Market Betting On?

TradingKey - U.S. tech media outlet The Information reports that SpaceX plans to file an IPO prospectus with regulators as early as this week or next. Advisors expect the offering could raise more than $75 billion.

Tradingkey

KeyAI

